title: Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus.
authors.affiliation: Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon' tkarageorgas@gmail.com.
authors.forename: Theofanis
authors.initials: T
authors.lastname: Karageorgas
authors.affiliation: Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon'.
authors.forename: Athanasios
authors.initials: A
authors.lastname: Zomas
authors.affiliation: Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon'.
authors.forename: Pinelopi
authors.initials: P
authors.lastname: Kazakou
authors.affiliation: Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon'.
authors.forename: Pelagia
authors.initials: P
authors.lastname: Katsimbri
authors.affiliation: 1st Department of Internal Medicine, University Hospital of Athens 'Laiko', Athens, Greece.
authors.forename: Marina
authors.initials: M
authors.lastname: Mantzourani
authors.affiliation: Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens 'Attikon'.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Boumpas
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000209:etiology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C527517:ofatumumab